EUVIMEDEUVIMED entdecken
Crossref

TLE1 in Prognosis Prediction in Lung Adenocarcinoma and the Importance of New Targeted Therapies.

Gabriel Maciel Almeida, Eduarda Severo Alvarenga, Carlos Alberto Barbosa Neto, Fabrícia Cardoso Marques, Bárbara Castro Carneiro, Gabriel Sampaio Feitosa, Júlia Matos Dubanhevitz, João Luiz Lima Pinheiro, Abel Caminha Barreto Neto, Markus Andret Cavalcante Gifoni

Brazilian Journal of Oncology · 26.06.2026 · 22 (CP)

DOI: 10.1055/s-0046-1825404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brazilian Journal of Oncology, erschienen am 26.06.2026. Verfasst von Gabriel Maciel Almeida und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All articles of this category (opens in new window) Address for correspondence Júlia Matos Dubanhevitz (geeoncirurgiaufc@gmail.com)

Introduction

Lung cancer is the leading cause of cancer-related mortality in Brazil, according to data from INCA, with pulmonary adenocarcinoma showing an increased incidence in recent years. In light of this, it is of utmost importance to seek new strategies to understand patient prognosis, one of which is the analysis of tumor gene expression. The expression of the TLE1 gene, which is intrinsically related to mechanisms of tumor progression and resistance to EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) therapies, may be of great utility for prognostic prediction and for indicating better treatment options, such as the use of antibody-drug conjugate therapies .

Objective

This study aims to highlight the impact of TLE1 gene expression on the overall survival of patients with lung adenocarcinoma and the importance of researching new targeted therapies for the treatment of this neoplasm.

Method

The TLE1 gene was selected through a literature review. Public databases from the UALCAN portal were used for gene expression and overall survival analysis of the TLE1 gene. Gene expression was assessed by comparing tumor tissue samples and normal tissue samples using the Wilcoxon test. Patients were then divided into two groups: “high expression” and “low/medium expression.” Survival comparison was performed using Kaplan-Meier curves and the log-rank test .

Results

In the gene expression analysis, TLE1 was significantly overexpressed in tumor tissue samples compared to normal tissue samples (p

Zitieren

APA

Almeida, G. M., Alvarenga, E. S., Neto, C. A. B., Marques, F. C., Carneiro, B. C., Feitosa, G. S., Dubanhevitz, J. M., Pinheiro, J. L. L., Neto, A. C. B., & Gifoni, M. A. C. (2026). TLE1 in Prognosis Prediction in Lung Adenocarcinoma and the Importance of New Targeted Therapies. Brazilian Journal of Oncology, 22(CP). https://doi.org/10.1055/s-0046-1825404

Vancouver

Almeida GM, Alvarenga ES, Neto CAB, Marques FC, Carneiro BC, Feitosa GS, et al. TLE1 in Prognosis Prediction in Lung Adenocarcinoma and the Importance of New Targeted Therapies. Brazilian Journal of Oncology. 2026;22(CP). doi:10.1055/s-0046-1825404

BibTeX
@article{Almeida2026,
  author = {Almeida, Gabriel Maciel and Alvarenga, Eduarda Severo and Neto, Carlos Alberto Barbosa and Marques, Fabrícia Cardoso and Carneiro, Bárbara Castro and Feitosa, Gabriel Sampaio and Dubanhevitz, Júlia Matos and Pinheiro, João Luiz Lima and Neto, Abel Caminha Barreto and Gifoni, Markus Andret Cavalcante},
  title = {TLE1 in Prognosis Prediction in Lung Adenocarcinoma and the Importance of New Targeted Therapies},
  journal = {Brazilian Journal of Oncology},
  year = {2026},
  volume = {22},
  number = {CP},
  doi = {10.1055/s-0046-1825404}
}
Kostenlos starten →